The Spanish cosmetic efficacy testing laboratory will exhibit at four major industry events in São Paulo, Paris, Barcelona and Bangkok, consolidating a year of business growth, team expansion and increased international activity.

As part of this international strategy, Dermaclaim Lab will exhibit at four major cosmetic industry events before the end of the year: in-cosmetics Latin America in São Paulo (23–24 September, Booth C90), Cosmetic 360 in Paris (14–15 October, Stand LB40), Cosmetorium in Barcelona (21–22 October, Stand 112), and in-cosmetics Asia in Bangkok (3–5 November, Booth AA68, Spanish Pavilion).

These events will complete an extensive 2026 international calendar and provide new opportunities to meet cosmetic manufacturers and active ingredient companies from Europe, Latin America and Asia.

 

Growing alongside the demand for stronger cosmetic efficacy evidence

Founded in Valencia in 2021, Dermaclaim Lab has experienced sustained growth driven by increasing demand for robust scientific evidence to substantiate cosmetic efficacy and functionality claims. This growth has been accompanied by an expansion of the company’s scientific team across both its Laboratory and Clinical departments, together with continued investment in advanced methodologies and technologies for cosmetic research.

Dermaclaim Lab provides an integrated portfolio of in vitro, ex vivo and clinical studies, allowing cosmetic companies to investigate the biological activity and mechanism of action of their innovations and subsequently demonstrate their efficacy in human volunteers. Its laboratory capabilities include human cell cultures, reconstructed 3D skin models and human skin explants, together with endpoints such as gene and protein expression, biomarkers, histology and immunohistochemistry.

Clinical studies combine advanced imaging technologies, instrumental measurements, expert clinical assessment and consumer perception to substantiate claims across areas including anti-ageing, wrinkles, firmness, pigmentation, hydration and skin barrier, sensitive skin, scalp care, hair growth and hair loss, among many other cosmetic applications.

 

Supporting the next generation of cosmetic innovation

The company’s international expansion reflects a broader evolution in the cosmetics industry, where manufacturers and ingredient developers increasingly require efficacy evidence that is not only statistically significant, but also scientifically relevant, reproducible and suitable for communication to customers and consumers. Dermaclaim Lab’s approach is based on combining scientific rigor with customized study design, rapid project execution and comprehensive scientific reporting.

The upcoming exhibitions will therefore be an opportunity for companies already working on their 2027 innovation pipelines to discuss new active ingredients, formulations, mechanisms of action and efficacy claims directly with the Dermaclaim Lab team.

 

📍 in-cosmetics Latin America – São Paulo 🇧🇷
23–24 September 2026 | Booth C90

📍 Cosmetic 360 – Paris 🇫🇷
14–15 October 2026 | Stand LB40

📍 Cosmetorium – Barcelona 🇪🇸
21–22 October 2026 | Stand 112

📍 in-cosmetics Asia – Bangkok 🇹🇭
3–5 November 2026 | Booth AA68 – Spanish Pavilion

Dermaclaim Lab – Test & Trust
Cosmetic claims substantiation | In vitro • Ex vivo • Clinical